ERCC1 Asn118Asn(rs11615)和ERCC2 Lys751Gln(rs13181)基因多态性与胆囊癌的关联性研究

被引:1
|
作者
幸赞西 [1 ]
包昶宇 [1 ]
机构
[1] 重庆市红十字会医院(江北区人民医院)普外科
关键词
胆囊癌; 基因多态性; 基因型;
D O I
暂无
中图分类号
R735.8 [胆囊、胆道肿瘤];
学科分类号
100214 ;
摘要
目的探讨ERCC1 Asn118Asn(rs11615)和ERCC2 Lys751Gln(rs13181)单核苷酸多态性与胆囊癌的关系。方法选择2014年5月至2016年5月期间重庆市红十字会医院普外科收治的50例胆囊癌病人为胆囊癌组,应用聚合酶链反应检测ERCC1 Asn118Asn(rs11615)和ERCC2 Lys751Gln(rs13181)基因多态性,比较胆囊癌组与健康人群(对照组)ERCC1 Asn118Asn(rs11615)和ERCC2 Lys751Gln(rs13181)基因型的分布频率差异以及等位基因频率差异。结果胆囊癌组和对照组ERCC1 Asn118Asn(rs11615)基因型分布频率野生型CC为54%比66%,杂合型CT为26%比26%,突变型TT为20%比8%,两组比较差异有统计学意义(χ;=7.05,P=0.028),等位基因频率野生型C为67%比79%,突变型T为33%比21%,两组比较差异有统计学意义(χ;=5.27,P=0.026)。ERCC2 Lys751Gln(rs13181)基因型分布频率野生型AA为20%比56%,杂合型AB为44%比32%,突变型BB为36%比12%,两组比较差异无统计学意义(χ;=0.83,P=0.669),等位基因频率野生型A为42%比72%,突变型B为58%比28%,两组比较差异有统计学意义(χ;=0.75,P=0.448)。结论胆囊癌的发生可能与ERCC1 Asn118Asn(rs11615)和ERCC2 Lys751Gln(rs13181)基因型多态性具有某种关联。
引用
收藏
页码:1098 / 1100
页数:3
相关论文
共 7 条
  • [1] Relationship Between Expression of Proteins ERCC1, ERCC2, and XRCC1 and Clinical Outcomes in Patients with Rectal Cancer Treated with FOLFOX-Based Preoperative Chemoradiotherapy[J] . Ming-Yii Huang,Joh-Jong Huang,Chun-Ming Huang,Chih-Hung Lin,Hsiang-Lin Tsai,Ching-Wen Huang,Chee-Yin Chai,Chia-Yang Lin,Jaw-Yuan Wang.World Journal of Surgery . 2017 (11)
  • [2] Prognostic implication of ERCC1 protein expression in resected oropharynx and oral cavity cancer
    An, Ho Jung
    Jo, Heejoon
    Jung, Chan Kwon
    Kang, Jin Hyoung
    Kim, Min Sik
    Sun, Dong-Il
    Cho, Kwang Jae
    Cho, Jung-Hae
    Won, Hye Sung
    Sun, Der Sheng
    Ko, Yoon Ho
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2017, 213 (08) : 949 - 955
  • [3] Multiple repair pathways mediate cellular tolerance to resveratrol-induced DNA damage[J] . Ying Liu,Xiaohua Wu,Xiaoqing Hu,Ziyuan Chen,Hao Liu,Shunichi Takeda,Yong Qing.Toxicology in Vitro . 2017
  • [4] Nucleotide excision repair in humans[J] . Graciela Spivak.DNA Repair . 2015
  • [5] Gallbaldder perforation causing a subcutaneous abscess
    Misiakos, Evangelos
    Tzepi, Ira
    Brountzos, Ilias
    Zavras, Nick
    Charalampopoulos, Anestis
    Macheras, Anastasios
    [J]. INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 2014, 5 (12): : 1088 - 1090
  • [6] The association between the ERCC1/2 polymorphisms and the clinical outcomes of the platinum-based chemotherapy in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis[J] . Yanlong Yang,Lei Xian.Tumor Biology . 2014 (4)
  • [7] Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy
    Ryu, JS
    Hong, YC
    Han, HS
    Lee, JE
    Kim, S
    Parke, YM
    Kim, YC
    Hwang, TS
    [J]. LUNG CANCER, 2004, 44 (03) : 311 - 316